A Phase 1, Open-Label, Randomized, 2-Period, Crossover Study to Evaluate the Effect of Food on the Single-Dose Pharmacokinetics of INCB123667 When Administered Orally to Healthy Adult Participants
Latest Information Update: 08 Apr 2025
At a glance
- Drugs INCB 123667 (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics
- Sponsors Incyte Corporation
- 08 Apr 2025 New trial record